CHRISTY SWINNEY: Open Payments
NPI 1023281508 · BIG STONE GAP, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 36 payments from 12 companies in 2025. Trend: 2023 $1,084 · 2024 $596 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $201 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| ABBVIE INC. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $47 |
| Ardelyx, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: CAPLYTA, XIFAXAN, FARXIGA, Auvelity, QULIPTA, Rybelsus, UBRELVY, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
